focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

FTSE 100 lags European peers as GSK, stronger pound weigh

Mon, 07th Nov 2022 17:46

FTSE 100 down 0.5%, FTSE 250 adds 1.2%

*

GSK down on failed late-stage study

*

Joules falls on suffering sales

Nov 7 (Reuters) - Britain's FTSE 100 slipped on Monday, lagging its European peers, as a stronger pound and a fall in the shares of drugmaker GSK offset optimism over China potentially easing its zero COVID-19 policy despite denials from Beijing officials.

The blue-chip FTSE 100 slipped 0.5% after hitting an a more than seven-week high on Friday, driven by gains in China-exposed miners. The wider European STOXX 600 index closed up 0.3%.

Among the biggest drags on FTSE 100 was GSK Plc, down 4.7%, after it said its blood cancer drug Blenrep failed the main goal of a late-stage study. The wider pharma index was down 1.6%.

Meanwhile, the pound gained nearly 0.9%, denting shares of dollar earners such as AstraZeneca and Diageo .

However, the mid-cap FTSE 250 rose 1.2%, mirroring a risk-on sentiment in global stocks despite mixed signals about China possibly reversing its zero COVID policy.

"The latest U.S. jobs report and a denial of any easing of China's zero COVID measures have failed to dent market optimism it seems, a sign perhaps that the buyers have control for the time being," said Chris Beauchamp, chief market analyst at online trading platform IG.

The focus this week will be on a preliminary reading of Britain's third-quarter GDP on Friday and the budget plan next week. The markets took comfort last week as the Bank of England indicated that interest rates would increase at a slower pace than current market expectations.

Shares of Joules Group plunged 23.5% after the struggling British fashion retailer said its sales in the 11 weeks to Oct. 30 were lower than expectations as it discusses a potential cornerstone investment in an equity raise.

Flutter Entertainment jumped 2.7% after it said that the arbitrator was in favour of the firm's valuation of FanDuel at $20 billion, ending its legal battle with FOX corporation. (Reporting by Johann M Cherian and Shruthi Shankar in Bengaluru; Editing by Sherry Jacob-Phillips, Shinjini Ganguli and Alison Williams)

Related Shares

More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...

17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.